Cargando…

Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer

Overcoming tumor heterogeneity is a major challenge for personalized treatment of gastric cancer, especially for human epidermal growth factor receptor‐2 targeted therapy. Analysis of circulating tumor DNA allows a more comprehensive analysis of tumor heterogeneity than traditional biopsies in lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jing, Wang, Haixing, Zang, Wanchun, Li, Beifang, Rao, Guanhua, Li, Lei, Yu, Yang, Li, Zhongwu, Dong, Bin, Lu, Zhihao, Jiang, Zhi, Shen, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581520/ https://www.ncbi.nlm.nih.gov/pubmed/28677165 http://dx.doi.org/10.1111/cas.13314

Ejemplares similares

Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
por: Niu, Dongfeng, et al.
Publicado: (2020)

RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
por: Yao, Jiannan, et al.
Publicado: (2018)

Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
por: Zhang, Mengqi, et al.
Publicado: (2022)

Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer
por: Chen, Zuhua, et al.
Publicado: (2019)

Circulating Tumor DNA Testing Overcomes Limitations of Comprehensive Genomic Profiling from Tumor Tissue
por: Kumar, Anivarya, et al.
Publicado: (2023)

Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors
por: Tian, Tiantian, et al.
Publicado: (2016)

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)

Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
por: Chen, Yang, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
por: Chen, Zuhua, et al.
Publicado: (2018)

Addressing cellular heterogeneity in tumor and circulation for refined prognostication
por: Lim, Su Bin, et al.
Publicado: (2019)

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer
por: Zhang, Meng, et al.
Publicado: (2023)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity Matters
por: Lim, Su Bin, et al.
Publicado: (2019)

Evaluation and consequences of heterogeneity in the circulating tumor cell compartment
por: Brouwer, Anja, et al.
Publicado: (2016)

Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
por: Xie, Ya-Jia, et al.
Publicado: (2023)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
por: Gao, Jian-Peng, et al.
Publicado: (2018)

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors
por: Gao, Jing, et al.
Publicado: (2016)

Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB
por: Fridland, Stanislav, et al.
Publicado: (2021)

Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
por: Jonsson, Vanessa D., et al.
Publicado: (2017)

Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies
por: Park, Jeong A, et al.
Publicado: (2022)

Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer
por: Zhu, Yan, et al.
Publicado: (2015)

Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA
por: Sasaki, Noriyuki, et al.
Publicado: (2020)

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC
por: Zhang, Yujuan, et al.
Publicado: (2021)

Molecular characterization and heterogeneity of circulating tumor cells in breast cancer
por: Jakabova, Anna, et al.
Publicado: (2017)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2018)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
por: Agnoletto, Chiara, et al.
Publicado: (2019)

Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
por: Savelieva, Olga E., et al.
Publicado: (2020)

Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
por: Agnoletto, Chiara, et al.
Publicado: (2021)

Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis
por: Gao, Yunhe, et al.
Publicado: (2016)

Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study
por: Gu, Jincui, et al.
Publicado: (2017)

Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer
por: Ning, Dawei, et al.
Publicado: (2021)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues
por: Hu, Qikang, et al.
Publicado: (2023)

Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity
por: Fomitcheva-Khartchenko, Anna, et al.
Publicado: (2021)

Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells
por: Dai, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ugcm756l00apc6fdmas9iihlq